A comparative pharmacokinetic study: 5 Fluorouracil (5FU) provided as patient specific individual doses and as standard doses according to a 'dose banding' principle
Not Applicable
Completed
- Conditions
- Cancer: BreastCancerBreast cancer
- Registration Number
- ISRCTN46112469
- Lead Sponsor
- Department of Health
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 26
Inclusion Criteria
Women with breast cancer who are receiving adjuvant therapy.
Exclusion Criteria
Patients on reduced doses of FEC chemotherapy, with known liver metastases, who have received chemotherapy for previous malignancies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method